ALCON INC (2U3.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:2U3 - CH0432492467 - Common Stock
69.82 EUR
+1.98 (+2.92%)
2U3 gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 63 industry peers in the Health Care Equipment & Supplies industry. 2U3 has only an average score on both its financial health and profitability. 2U3 is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
2U3 had positive earnings in the past year.
2U3 had a positive operating cash flow in the past year.
2U3 had positive earnings in 4 of the past 5 years.
2U3 had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
2U3 has a Return On Assets (3.32%) which is comparable to the rest of the industry.
2U3's Return On Equity of 4.74% is in line compared to the rest of the industry. 2U3 outperforms 44.44% of its industry peers.
With a Return On Invested Capital value of 3.94%, 2U3 is not doing good in the industry: 63.49% of the companies in the same industry are doing better.
2U3 had an Average Return On Invested Capital over the past 3 years of 3.01%. This is significantly below the industry average of 9.81%.
The last Return On Invested Capital (3.94%) for 2U3 is above the 3 year average (3.01%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.32% | ||
| ROE | 4.74% | ||
| ROIC | 3.94% |
ROA(3y)2.6%
ROA(5y)1.44%
ROE(3y)3.72%
ROE(5y)2.06%
ROIC(3y)3.01%
ROIC(5y)N/A
1.3 Margins
With a decent Profit Margin value of 10.28%, 2U3 is doing good in the industry, outperforming 69.84% of the companies in the same industry.
In the last couple of years the Profit Margin of 2U3 has grown nicely.
The Operating Margin of 2U3 (13.63%) is better than 63.49% of its industry peers.
2U3's Operating Margin has improved in the last couple of years.
2U3 has a Gross Margin of 54.26%. This is comparable to the rest of the industry: 2U3 outperforms 46.03% of its industry peers.
In the last couple of years the Gross Margin of 2U3 has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.63% | ||
| PM (TTM) | 10.28% | ||
| GM | 54.26% |
OM growth 3Y6.79%
OM growth 5Y35.45%
PM growth 3Y31.33%
PM growth 5YN/A
GM growth 3Y-0.59%
GM growth 5Y2.7%
2. Health
2.1 Basic Checks
2U3 has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for 2U3 has been increased compared to 1 year ago.
2U3 has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, 2U3 has an improved debt to assets ratio.
2.2 Solvency
2U3 has an Altman-Z score of 4.16. This indicates that 2U3 is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of 2U3 (4.16) is better than 71.43% of its industry peers.
The Debt to FCF ratio of 2U3 is 3.63, which is a good value as it means it would take 2U3, 3.63 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of 2U3 (3.63) is better than 71.43% of its industry peers.
A Debt/Equity ratio of 0.21 indicates that 2U3 is not too dependend on debt financing.
2U3 has a better Debt to Equity ratio (0.21) than 69.84% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 3.63 | ||
| Altman-Z | 4.16 |
ROIC/WACC0.84
WACC4.69%
2.3 Liquidity
2U3 has a Current Ratio of 2.12. This indicates that 2U3 is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of 2U3 (2.12) is better than 65.08% of its industry peers.
2U3 has a Quick Ratio of 1.30. This is a normal value and indicates that 2U3 is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.30, 2U3 is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.12 | ||
| Quick Ratio | 1.3 |
3. Growth
3.1 Past
2U3 shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -0.66%.
Measured over the past years, 2U3 shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.04% on average per year.
Looking at the last year, 2U3 shows a small growth in Revenue. The Revenue has grown by 4.34% in the last year.
The Revenue has been growing slightly by 5.71% on average over the past years.
EPS 1Y (TTM)-0.66%
EPS 3Y12.36%
EPS 5Y10.04%
EPS Q2Q%-2.47%
Revenue 1Y (TTM)4.34%
Revenue growth 3Y6.13%
Revenue growth 5Y5.71%
Sales Q2Q%5.5%
3.2 Future
Based on estimates for the next years, 2U3 will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.51% on average per year.
2U3 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.02% yearly.
EPS Next Y0.73%
EPS Next 2Y7.72%
EPS Next 3Y9.41%
EPS Next 5Y10.51%
Revenue Next Year5.2%
Revenue Next 2Y6.27%
Revenue Next 3Y6.4%
Revenue Next 5Y6.02%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 27.06, which means the current valuation is very expensive for 2U3.
2U3's Price/Earnings ratio is a bit cheaper when compared to the industry. 2U3 is cheaper than 61.90% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.49. 2U3 is around the same levels.
2U3 is valuated rather expensively with a Price/Forward Earnings ratio of 22.97.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 2U3 is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 23.69. 2U3 is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.06 | ||
| Fwd PE | 22.97 |
4.2 Price Multiples
2U3's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, 2U3 is valued a bit cheaper than the industry average as 68.25% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 28.19 | ||
| EV/EBITDA | 16.42 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 2U3 does not grow enough to justify the current Price/Earnings ratio.
2U3 has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)37.05
PEG (5Y)2.69
EPS Next 2Y7.72%
EPS Next 3Y9.41%
5. Dividend
5.1 Amount
2U3 has a yearly dividend return of 0.44%, which is pretty low.
2U3's Dividend Yield is comparable with the industry average which is at 2.14.
Compared to an average S&P500 Dividend Yield of 2.31, 2U3's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.44% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
15.85% of the earnings are spent on dividend by 2U3. This is a low number and sustainable payout ratio.
DP15.85%
EPS Next 2Y7.72%
EPS Next 3Y9.41%
FRA:2U3 (12/5/2025, 7:00:00 PM)
69.82
+1.98 (+2.92%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners68.6%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap34.89B
Revenue(TTM)10.19B
Net Income(TTM)1.05B
Analysts79
Price Target92.84 (32.97%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.44% |
Yearly Dividend0.23
Dividend Growth(5Y)N/A
DP15.85%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.69%
Min EPS beat(2)2.89%
Max EPS beat(2)4.49%
EPS beat(4)3
Avg EPS beat(4)0.92%
Min EPS beat(4)-4.26%
Max EPS beat(4)4.49%
EPS beat(8)7
Avg EPS beat(8)2.38%
EPS beat(12)9
Avg EPS beat(12)2.81%
EPS beat(16)12
Avg EPS beat(16)4.78%
Revenue beat(2)0
Avg Revenue beat(2)-2.25%
Min Revenue beat(2)-2.97%
Max Revenue beat(2)-1.52%
Revenue beat(4)0
Avg Revenue beat(4)-2.12%
Min Revenue beat(4)-3.43%
Max Revenue beat(4)-0.56%
Revenue beat(8)0
Avg Revenue beat(8)-1.8%
Revenue beat(12)2
Avg Revenue beat(12)-1.03%
Revenue beat(16)4
Avg Revenue beat(16)-0.36%
PT rev (1m)-0.57%
PT rev (3m)0.49%
EPS NQ rev (1m)-6.41%
EPS NQ rev (3m)-6.39%
EPS NY rev (1m)-0.65%
EPS NY rev (3m)-1.16%
Revenue NQ rev (1m)-0.72%
Revenue NQ rev (3m)-0.58%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-0.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.06 | ||
| Fwd PE | 22.97 | ||
| P/S | 3.99 | ||
| P/FCF | 28.19 | ||
| P/OCF | 19.61 | ||
| P/B | 1.84 | ||
| P/tB | 11.11 | ||
| EV/EBITDA | 16.42 |
EPS(TTM)2.58
EY3.7%
EPS(NY)3.04
Fwd EY4.35%
FCF(TTM)2.48
FCFY3.55%
OCF(TTM)3.56
OCFY5.1%
SpS17.5
BVpS37.95
TBVpS6.29
PEG (NY)37.05
PEG (5Y)2.69
Graham Number46.94
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.32% | ||
| ROE | 4.74% | ||
| ROCE | 4.86% | ||
| ROIC | 3.94% | ||
| ROICexc | 4.16% | ||
| ROICexgc | 13.06% | ||
| OM | 13.63% | ||
| PM (TTM) | 10.28% | ||
| GM | 54.26% | ||
| FCFM | 14.15% |
ROA(3y)2.6%
ROA(5y)1.44%
ROE(3y)3.72%
ROE(5y)2.06%
ROIC(3y)3.01%
ROIC(5y)N/A
ROICexc(3y)3.18%
ROICexc(5y)N/A
ROICexgc(3y)10.24%
ROICexgc(5y)N/A
ROCE(3y)3.72%
ROCE(5y)N/A
ROICexgc growth 3Y2.95%
ROICexgc growth 5Y30.08%
ROICexc growth 3Y10.31%
ROICexc growth 5Y41.26%
OM growth 3Y6.79%
OM growth 5Y35.45%
PM growth 3Y31.33%
PM growth 5YN/A
GM growth 3Y-0.59%
GM growth 5Y2.7%
F-Score5
Asset Turnover0.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 3.63 | ||
| Debt/EBITDA | 1.7 | ||
| Cap/Depr | 48.06% | ||
| Cap/Sales | 6.2% | ||
| Interest Coverage | 7.46 | ||
| Cash Conversion | 76.71% | ||
| Profit Quality | 137.63% | ||
| Current Ratio | 2.12 | ||
| Quick Ratio | 1.3 | ||
| Altman-Z | 4.16 |
F-Score5
WACC4.69%
ROIC/WACC0.84
Cap/Depr(3y)77.98%
Cap/Depr(5y)73.14%
Cap/Sales(3y)9.96%
Cap/Sales(5y)10.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-0.66%
EPS 3Y12.36%
EPS 5Y10.04%
EPS Q2Q%-2.47%
EPS Next Y0.73%
EPS Next 2Y7.72%
EPS Next 3Y9.41%
EPS Next 5Y10.51%
Revenue 1Y (TTM)4.34%
Revenue growth 3Y6.13%
Revenue growth 5Y5.71%
Sales Q2Q%5.5%
Revenue Next Year5.2%
Revenue Next 2Y6.27%
Revenue Next 3Y6.4%
Revenue Next 5Y6.02%
EBIT growth 1Y5.55%
EBIT growth 3Y13.34%
EBIT growth 5Y43.18%
EBIT Next Year37.2%
EBIT Next 3Y18.41%
EBIT Next 5Y14.44%
FCF growth 1Y174.48%
FCF growth 3Y104.3%
FCF growth 5Y41.96%
OCF growth 1Y61.62%
OCF growth 3Y15.59%
OCF growth 5Y17.69%
ALCON INC / 2U3.DE FAQ
What is the ChartMill fundamental rating of ALCON INC (2U3.DE) stock?
ChartMill assigns a fundamental rating of 5 / 10 to 2U3.DE.
Can you provide the valuation status for ALCON INC?
ChartMill assigns a valuation rating of 3 / 10 to ALCON INC (2U3.DE). This can be considered as Overvalued.
Can you provide the profitability details for ALCON INC?
ALCON INC (2U3.DE) has a profitability rating of 6 / 10.
Can you provide the financial health for 2U3 stock?
The financial health rating of ALCON INC (2U3.DE) is 6 / 10.
Is the dividend of ALCON INC sustainable?
The dividend rating of ALCON INC (2U3.DE) is 2 / 10 and the dividend payout ratio is 15.85%.